FDA Documents of Aurobindo Pharma Limited - Unit IV
Aurobindo Pharma Limited - Unit IV is an organization that has been audited by the FDA 7 times between 2012 and 2019 across all 3 sites.
Documents
FDA 483 Aurobindo Pharma - Unit IV | Dec 2018
Available Now - $199
Issued on: Dec 14, 2018
Human Drug Form 483
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2019
Out-of-stock
Issued on: Nov 13, 2019
Human Drug Form 483
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2018
Out-of-stock
Issued on: Feb 20, 2018
Human Drug Form 483
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2017
Out-of-stock
Issued on: Apr 28, 2017
Human Drug Form 483
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2016
Out-of-stock
Issued on: Sep 16, 2016
Human Drug Form 483
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2014
Out-of-stock
Issued on: Sep 26, 2014
Human Drug Form 483
FDA Investigators(15)
- Dipesh K. Shah, FDA Investigator
- June P. Page, FDA Investigator
- Thomas J. Arista, FDA Investigator
- Marie B. Buen-Bigornia, FDA Investigator
- Freddy Ortiz Colon, FDA Investigator
- Ortiz Colon, Freddy, FDA Investigator
- Atul Agrawal, FDA Investigator
- Jose A. Cruz Gonzalez, FDA Investigator
- Cruz Gonzalez, Jose A, FDA Investigator
- Yasamin Ameri, FDA Investigator
- Scott T. Ballard, FDA Investigator
- Saleem A. Akhtar, FDA Investigator
- Nebil A. Oumer, FDA Investigator
- Barbara D. Paul, FDA Investigator
- Eric M. Mueller, FDA Investigator